WEST PALM BEACH, FL ― Among patients with relapsing multiple sclerosis (MS) and visual impairment who received a potential remyelinating treatment or placebo for as long as 36 weeks, median ...
The differentiation of oligodendrocyte progenitor cells (OPCs) into oligodendrocytes (OLs) promotes the remyelination in human brain. In multiple sclerosis (MS), dysfunctional OPC differentiation ...
BUFFALO, N.Y. — Remyelination, the spontaneous regeneration of the fatty insulator in the brain that keeps neurons communicating, has long been seen as crucial to the next big advance in treating ...
OKLAHOMA CITY, Oct. 9, 2025 /PRNewswire/ -- Cadenza Bio, Inc. today announced that a collaborative study, "Chloroindazole based Estrogen Receptor β ligands with favorable pharmacokinetics promote ...
A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.
EDINBURGH, Scotland--(BUSINESS WIRE)--Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological ...
Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results